Too good to be true? aspirin and schizophrenia

Journal of Clinical Psychopharmacology

Volumn 32, Issue 5, 2012, Pages 583-584

  Shader, Richard I ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOZAPINE; OLANZAPINE; OMEGA 3 FATTY ACID; PANTOPRAZOLE; RISPERIDONE;

ARTHRITIS; CHRONIC INFLAMMATION; DRUG ABSORPTION; EDITORIAL; HEADACHE; HUMAN; INJURY; MENTAL DISEASE; NULL HYPOTHESIS; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SCHIZOPHRENIA; STOMACH HEMORRHAGE; STOMACH PH; STUDY DESIGN; SYSTEMATIC ERROR; TREATMENT OUTCOME;

ASPIRIN; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SCHIZOPHRENIA;

EID: 84865863979     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31826c448b     Document Type: Editorial

References (4)

1. Popper K. The Logic of Scientific Discovery. Oxford, UK: Routledge/Taylor Francis; 1959.
2. Laan W, Grobbee DE, Selten JP, et al. Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results of a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2010;71:520-527.
3. Shuttleworth, Martyn. Experimental errors. Experiment-Resources, 2008. Available at: http://www.experiment-resources.com/type-I-error.html/. Accessed August 10, 2012.
4. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276.